• SPX
  • $5,893.62
  • 0.39 %
  • $23.00
  • DJI
  • $43,389.60
  • -0.13 %
  • -$55.39
  • N225
  • $38,429.32
  • 0.55 %
  • $208.69
  • FTSE
  • $8,109.32
  • 0.57 %
  • $45.71
  • IXIC
  • $18,791.81
  • 0.6 %
  • $111.69
Fractyl Health, Inc. Common Stock (GUTS) Stock Price, News & Analysis

Fractyl Health, Inc. Common Stock (GUTS) Stock Price, News & Analysis

Currency in USD Disclaimer

$2.07

$0.1

(5.09%)

Day's range
$1.91
Day's range
$2.14
50-day range
$1.91
Day's range
$3.48
  • Country: US
  • ISIN: N/A
52 wk range
$1.74
Day's range
$14.5
  • CEO: Dr. Harith Rajagopalan M.D., Ph.D.
  • Website: Visit Site


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score -3.57
  • Piotroski Score 4.00
  • Grade N/A
  • Symbol (GUTS)
  • Company Fractyl Health, Inc. Common Stock
  • Price $2.07
  • Changes Percentage (5.09%)
  • Change $0.1
  • Day Low $1.91
  • Day High $2.14
  • Year High $14.50

Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It also develops Rejuva, a novel virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is based in Lexington, Massachusetts.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) 11/12/2024
  • Fiscal Year End N/A

  • Average Stock Price Target $0.00
  • High Stock Price Target $0.00
  • Low Stock Price Target $0.00
  • Potential Upside/Downside N/A
  • Consensus Rating Strong Sell
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) $0.00
  • Trailing P/E Ratio N/A
  • Forward P/E Ratio N/A
  • P/E Growth N/A
  • Net Income $-77,091,000

Income Statement

Quarterly

Annual

Latest News of GUTS

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Fractyl Health, Inc. Common Stock Frequently Asked Questions

  • What were the earnings of GUTS in the last quarter?

    In the last quarter Fractyl Health, Inc. Common Stock earnings were on Wednesday, August, 14th. The Fractyl Health, Inc. Common Stock maker reported -$0.36 EPS for the quarter, beating analysts' consensus estimates of -$0.46 by $0.10.

  • What is the Fractyl Health, Inc. Common Stock stock price today?

    Today's price of Fractyl Health, Inc. Common Stock is $2.07 — it has increased by +5.09% in the past 24 hours. Watch Fractyl Health, Inc. Common Stock stock price performance more closely on the chart.

  • Does Fractyl Health, Inc. Common Stock release reports?

    Yes, you can track Fractyl Health, Inc. Common Stock's financials in yearly and quarterly reports directly on Stocks.News.

  • What is the Fractyl Health, Inc. Common Stock stock forecast?

    Watch the Fractyl Health, Inc. Common Stock chart and read a more detailed Fractyl Health, Inc. Common Stock stock forecast to see what analysts suggest you do with its shares.

  • What is Fractyl Health, Inc. Common Stock stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NASDAQ, exchange stock trades by Fractyl Health, Inc. Common Stock stock ticker.

  • How to buy Fractyl Health, Inc. Common Stock stocks?

    Like other stocks, GUTS shares are sold on stock exchanges such as NASDAQ. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is Fractyl Health, Inc. Common Stock's EBITDA?

    Fractyl Health, Inc. Common Stock measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in Fractyl Health, Inc. Common Stock’s financial statements.

  • What is the Fractyl Health, Inc. Common Stock's net income ratio for the financial year 2023?

    The net income ratio for the financial year 2023 is -642.425, which equates to approximately -64,242.50%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in Fractyl Health, Inc. Common Stock stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including Fractyl Health, Inc. Common Stock's financials relevant news, and technical analysis. Fractyl Health, Inc. Common Stock's technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for Fractyl Health, Inc. Common Stock stock currently indicates a “sell” signal. For more insights, review Fractyl Health, Inc. Common Stock’s technical analysis.

  • A revenue figure for Fractyl Health, Inc. Common Stock for its last quarter?

    Fractyl Health, Inc. Common Stock published it's last quarterly revenues at $43,000.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.